Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ha Linh Vu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pigment Cell & Melanoma Research|March 14, 2012
The Yin-Yang of RAF inhibitorsHa Linh Vu, Andrew E Aplin
Molecular Cancer Research : MCR|June 26, 2014
Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanomaHa Linh Vu, Andrew E Aplin
Pharmacological Research|March 19, 2016
Targeting mutant NRAS signaling pathways in melanomaHa Linh Vu, Andrew E Aplin
The Journal of Clinical and Aesthetic Dermatology|January 19, 2018
Acne Scarring-Pathogenesis, Evaluation, and Treatment OptionsDeirdre Connolly, Ha Linh Vu, Kavita Mariwalla, et al.
Cancer Letters|July 25, 2009
HPV-induced oropharyngeal cancer, immune response and response to therapyHa Linh Vu, Andrew G Sikora, Shibo Fu, et al.
Pigment Cell & Melanoma Research|July 16, 2015
RAC1 P29S regulates PD-L1 expression in melanomaHa Linh Vu, Sheera Rosenbaum, Timothy J Purwin, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Cancer|June 23, 2009
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancerJohnny Kao, Ha Linh Vu, Eric M Genden, et al.
Cancer|June 19, 2009
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary responseJohnny Kao, Stuart Packer, Ha Linh Vu, et al.
Journal of Cell Science & Therapy|March 14, 2013
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance RadiotherapyShibo Fu, Michael Rivera, Eric C Ko, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pigment Cell & Melanoma Research|March 14, 2012
The Yin-Yang of RAF inhibitorsHa Linh Vu, Andrew E Aplin
Molecular Cancer Research : MCR|June 26, 2014
Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanomaHa Linh Vu, Andrew E Aplin
Pharmacological Research|March 19, 2016
Targeting mutant NRAS signaling pathways in melanomaHa Linh Vu, Andrew E Aplin
The Journal of Clinical and Aesthetic Dermatology|January 19, 2018
Acne Scarring-Pathogenesis, Evaluation, and Treatment OptionsDeirdre Connolly, Ha Linh Vu, Kavita Mariwalla, et al.
Cancer Letters|July 25, 2009
HPV-induced oropharyngeal cancer, immune response and response to therapyHa Linh Vu, Andrew G Sikora, Shibo Fu, et al.
Pigment Cell & Melanoma Research|July 16, 2015
RAC1 P29S regulates PD-L1 expression in melanomaHa Linh Vu, Sheera Rosenbaum, Timothy J Purwin, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Cancer|June 23, 2009
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancerJohnny Kao, Ha Linh Vu, Eric M Genden, et al.
Cancer|June 19, 2009
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary responseJohnny Kao, Stuart Packer, Ha Linh Vu, et al.
Journal of Cell Science & Therapy|March 14, 2013
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance RadiotherapyShibo Fu, Michael Rivera, Eric C Ko, et al.
Pageof 2